Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/NP5 stock hub

ETR/NP5 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/NP5is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

297.4M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/NP5

In the news

Latest news · ETR/NP5

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROEn/a

P25 -6.7P50 8.5P75 17.2

ROIC-23.3

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/NP5 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

EUR

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	DE
Employees	27
Employees Change	-1%
Employees Change Percent	-4.35
Enterprise value	EUR 306.9M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0004147952
Last refreshed	2026-05-10
Market cap	EUR 297.4M
Price	EUR 14.8
Price currency	EUR
Rev Per Employee	708,370.37x
Sector	Healthcare
Sic	2836
Symbol	etr/NP5
Website	https://www.newron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.45%
EV Earnings	-23.18x
EV/FCF	9.5x
EV/Sales	15.77x
FCF yield	10.86%
P/B ratio	-26.71x
P/S ratio	15.55x
PE Ratio3 Y	15.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.56%
EBITDA Margin	-24.45%
FCF margin	168.89%
Gross margin	100%
Gross Profit	EUR 19.1M
Gross Profit Growth	-68.06%
Gross Profit Growth Q	-84.94%
Gross Profit Growth3 Y	40%
Gross Profit Growth5 Y	16.91%
Net Income	EUR -13.2M
Net Income Growth Years	0%
Pretax Margin	-64.59%
Profit Margin	-69.22%
Profit Per Employee	EUR -490,333
ROA	-5.65
Roa5y	-5.28
ROCE	46.62
ROIC	-23.34
Roic5y	-66.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	72.96%
Cagr3y	47.4%
Cagr5y	49.75%
EPS Growth Years	0
Revenue Growth	-62.78x
Revenue Growth Q	-84.94x
Revenue Growth Years	0x
Revenue Growth3 Y	40x
Revenue Growth5 Y	16.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.37
Assets	EUR 40.1M
Cash	EUR 28.9M
Current Assets	EUR 38.1M
Current Liabilities	EUR 50.1M
Debt	EUR 38.2M
Debt FCF	EUR 1.18
Equity	EUR -11.1M
Interest Coverage	-1.07
Liabilities	EUR 51.2M
Long Term Assets	EUR 2M
Long Term Liabilities	EUR 1.1M
Net Cash	EUR -9.3M
Net Cash By Market Cap	EUR -3.12
Net Debt FCF	EUR 0.29
Tangible Book Value	EUR -11.1M
Tangible Book Value Per Share	EUR -0.56
WACC	8.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.76
Net Working Capital	EUR -3.3M
Quick ratio	0.7
Working Capital	EUR -12.1M
Working Capital Turnover	EUR 1.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	72.9%
200-day SMA	16.77
3Y total return	220.35%
50-day SMA	17.59
50-day SMA vs 200-day SMA	50over200
5Y total return	652.8%
All Time High	34.65
All Time High Change	-57.29%
All Time High Date	2026-01-09
All Time Low	1.13
All Time Low Change	1,209.73%
All Time Low Date	2022-10-05
ATR	0.92
Beta	0.82
Ch YTD	-43.83
High	14.8
High52	34.65
High52 Date	2026-01-09
High52ch	-57.29%
Low	14.7
Low52	7.06
Low52 Date	2025-06-25
Low52ch	109.63%
Ma50ch	-15.84%
Price vs 200-day SMA	-11.76%
RSI	34.48
RSI Monthly	54.51
RSI Weekly	41.72
Sharpe ratio	1.13x
Sortino ratio	1.94
Total Return	2.98%
Tr YTD	-43.83
Tr1m	-4.82%
Tr1w	-6.92%
Tr3m	-29.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -4.7M
Operating margin	-24.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,905,113%
Net Borrowing	-13,781,000
Shares Insiders	10.54%
Shares Institutions	13.25%
Shares Qo Q	0.03%
Shares Yo Y	-2.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 32.1M
Average Volume	5,995.8x
Bv Per Share	-0.56
CAPEX	EUR -47,000
Ch1m	-4.82
Ch1w	-6.92
Ch1y	72.9
Ch3m	-29.19
Ch3y	220.3
Ch5y	652.8
Ch6m	-2.25
Change	-1.33%
Change From Open	0.68
Close	15
Days Gap	-2
Depreciation Amortization	21,000
Dollar Volume	636.4
Earnings Date	2026-09-22
EBIT	EUR -4.7M
EBITDA	EUR -4.7M
EPS	EUR -0.66
F Score	2
FCF	EUR 32.3M
FCF EV Yield	10.53x
Financing CF	-13,431,000
Fiscal Year End	December
Founded	1,999
Income Tax	EUR 885,000
Investing CF	-13,664,000
Is Primary Listing	0
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Ma150	19.36
Ma150ch	-23.55%
Ma20	16.8
Ma20ch	-11.89%
Net CF	5,254,000
Next Earnings Date	2026-09-22
Open	14.7
P FCF Ratio	9.21
P OCF Ratio	9.19
Position In Range	100
Ppne	736,000
Price Date	2026-05-08
Relative Volume	0.01x
Revenue	19,126,000x
SBC By Revenue	1.11x
Share Based Comp	212,000
Tax By Revenue	4.63x
Tr6m	-2.25%
Volume	43
Z Score	1.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/NP5 pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/NP5 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/NP5?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.2%

Share of float held by funds and institutions

Insider ownership

+10.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.0%

Negative means the company is buying back shares.

Technical

ETR/NP5 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.5

Neutral momentum band

Price vs 200-day MA

-11.8%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/NP5

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/NP5 stock rating?

etr/NP5 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/NP5 analysis?

The full report lives at /stocks/etr/NP5/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/NP5?

The latest report frames etr/NP5 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/NP5 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.